急性肾小管间质性肾炎的病因与肾脏结局:中国单中心前瞻性队列研究
该研究纳入157例经活检证实的急性肾小管间质性肾炎(ATIN)患者,随访至少24个月,平均48个月。随访后病因谱修正:药物性ATIN比例从活检时64%降至50%,自身免疫相关ATIN从22%升至41%。女性、高龄、高血压和反复肾损伤是肾脏结局不良的独立危险因素。
要点
- 自身免疫相关ATIN可在肾损伤后出现全身表现,易被误诊为药物性或不明原因ATIN。
- 反复肾损伤在TINU综合征(51%)、自身免疫病(53%)和药物性ATIN(8%)中均可见。
- 女性、高龄、高血压和反复肾损伤是肾脏结局不良的独立危险因素。
核心结论
- 自身免疫相关ATIN可能在肾损伤后才出现全身表现,常被误诊。
- ATIN患者反复肾损伤并不少见,计划性随访对明确病因和正确管理至关重要。
研究设计与样本
- 单中心前瞻性队列研究,纳入2005年1月1日至2013年12月31日北京大学第一医院经活检证实的ATIN患者157例,随访至少24个月,平均48个月(范围24-108个月)。
主要发现
- 随访后病因谱修正:药物性ATIN比例从活检时64%降至50%,自身免疫相关ATIN从22%升至41%。
- 反复肾损伤发生率:TINU综合征51%,自身免疫病53%,药物性ATIN 8%。
- 12个月时eGFR<60 mL/min/1.73 m2的比例:药物性ATIN 47%,TINU 74%,其他自身免疫病57%。
- 多因素分析显示女性、高龄、高血压和反复肾损伤是肾脏结局不良的独立危险因素。
关键数值与推荐
- 12个月时eGFR<60 mL/min/1.73 m2定义为肾功能下降。
- 肾脏结局不良的独立危险因素:女性、高龄、高血压、反复肾损伤。
临床怎么用
- 对ATIN患者应进行计划性随访,以及时识别迟发的自身免疫表现并修正病因诊断。
- 关注反复肾损伤,尤其TINU综合征和自身免疫病患者,可能需要延长免疫抑制治疗。
- 女性、高龄、高血压患者应加强监测,警惕肾脏结局不良。
局限性
- 单中心研究,样本量157例,结果外推需谨慎。
- 随访时间平均48个月,更长结局未评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to explore the etiology, long-term renal outcomes and affecting factors of acute tubulointerstitial nephritis (ATIN). METHODS: Patients with biopsy-proven ATIN from 1 January 2005 to 31 December 2013 at Peking University First Hospital were enrolled in the study and received scheduled follow-up for at least 24 months. The causes of ATIN were defined at biopsy and reclassified during follow-up. Factors affecting renal recovery at 6 months post-biopsy and estimated glomerular filtration rate (eGFR) at 12 months post-biopsy and at the end of follow-up were analyzed. RESULTS: A total of 157 ATIN patients were enrolled, with an average follow-up of 48 months (range 24-108 months). A modified etiology spectrum was identified, with a decreased proportion of drug-induced ATIN (D-ATIN, 64% at biopsy to 50% after follow-up) and an increase in autoimmune-related ATIN (22-41%) with late-onset systemic manifestations in patients who had been classified as D-ATIN or ATIN of unknown cause. Recurrent kidney injury was observed in 51% of the patients with tubulointerstitial nephritis and uveitis syndrome (TINU), 53% of those with an autoimmune disease and 8% of those with D-ATIN, resulting in prolonged immunosuppressive treatment. By 12 months, decreased eGFR (<60 mL/min/1.73 m2) was observed in 47% of the patients with D-ATIN, 74% of those with TINU and 57% of those with other autoimmune diseases. In multivariable analysis, female sex, older age, presence of hypertension and recurrent kidney injury were independent risk factors for worse renal outcomes. CONCLUSIONS: Our data demonstrate that autoimmune-related ATIN may present with systemic manifestations after kidney injury and is, therefore, commonly misdiagnosed. Repeated kidney injury is not uncommon in patients with ATIN. Scheduled follow-up is, therefore, critical for defining the exact etiology and proper management of ATIN.
引用
- Su T, Gu Y, Sun P, et al. Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China. Nephrol Dial Transplant. 2018. PMID: 28992223. doi:10.1093/ndt/gfx247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。